A detailed history of Acuitas Investments, LLC transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Acuitas Investments, LLC holds 554,500 shares of KRON stock, worth $526,775. This represents 0.26% of its overall portfolio holdings.

Number of Shares
554,500
Previous 443,457 25.04%
Holding current value
$526,775
Previous $549,000 0.91%
% of portfolio
0.26%
Previous 0.31%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$0.92 - $1.5 $102,159 - $166,564
111,043 Added 25.04%
554,500 $554,000
Q2 2024

Aug 05, 2024

BUY
$0.73 - $1.38 $1,716 - $3,244
2,351 Added 0.53%
443,457 $549,000
Q1 2024

May 10, 2024

BUY
$1.02 - $1.3 $115,392 - $147,069
113,130 Added 34.49%
441,106 $573,000
Q4 2023

Feb 02, 2024

SELL
$0.75 - $1.49 $633 - $1,259
-845 Reduced 0.26%
327,976 $409,000
Q3 2023

Oct 27, 2023

SELL
$1.23 - $2.25 $14 - $27
-12 Reduced -0.0%
328,821 $427,000
Q2 2023

Aug 07, 2023

BUY
$1.24 - $1.92 $407,752 - $631,359
328,833 New
328,833 $565,000

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $53.9M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Acuitas Investments, LLC Portfolio

Follow Acuitas Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuitas Investments, LLC with notifications on news.